Straits Times Index
3,255.54 +16.51 (+0.51%) S&P 500
3,971.27 -6.26 (-0.16%) Dow
32,394.25 -37.83 (-0.12%) Nasdaq
11,716.08 -52.76 (-0.45%) Bitcoin USD
27,277.54 +134.17 (+0.49%) CMC Crypto 200
598.52 +355.84 (+146.63%)
Sabra Health Care REIT, Inc. (SBRA)
After hours:
| Previous close | 10.70 |
| Open | 10.63 |
| Bid | 10.74 x 3000 |
| Ask | 10.75 x 3000 |
| Day's range | 10.57 - 10.81 |
| 52-week range | 10.08 - 16.60 |
| Volume | |
| Avg. volume | 1,950,883 |
| Market cap | 2.491B |
| Beta (5Y monthly) | 1.30 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.34 |
| Earnings date | 02 May 2023 - 08 May 2023 |
| Forward dividend & yield | 1.20 (11.21%) |
| Ex-dividend date | 10 Feb 2023 |
| 1y target est | 13.21 |
- Zacks
Implied Volatility Surging for Sabra Healthcare REIT (SBRA) Stock Options
Investors need to pay close attention to Sabra Healthcare REIT (SBRA) stock based on the movements in the options market lately.
- Motley Fool
This Dividend Stock Will Rise by 20%, Per Wall Street. Here's Why You Should Sell It.
Sabra Health Care REIT (NASDAQ: SBRA) is slated to grow by quite a bit, for a real estate business at least. The average of the estimates made by Wall Street analysts suggests that Sabra's stock price will climb by around 20% over the year from its current level of around $11.27 to reach roughly $13.58. As its name implies, Sabra is a real estate investment trust (REIT) that buys and rents out healthcare properties like behavioral health clinics, skilled nursing facilities, and even senior housing using sale-leaseback transactions, among other types of deals.
- Motley Fool
Beware Of These 2 High-Yield Dividend Stocks In 2023
Everyone loves a high dividend yield stock when it's paying out loads of cash, but nobody loves it when their quarterly financial rewards suddenly start to get a bit stingier without warning. In that vein, there are two passive income investments that are too risky to approach right now despite their ludicrously juicy yields. With an outrageously high forward dividend yield above 15.7%, even savvy investors are likely to at least take a closer look at AFC Gamma (NASDAQ: AFCG).
